| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4afb8b01aa8de7e0b24a86713b23a18 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate |
2004-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45566d8c1e80e3186175d4577f90016b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_491f73d41a2cd32e815f294ba9e9f85f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_368dfdb71f633caaa607f6e0712d1394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c8bc3218a829f5b7713dc73d8a47e50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4880860de6201baff1680faa3c624ef7 |
| publicationDate |
2006-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20060119982-A |
| titleOfInvention |
NOB-A binding molecule and pharmaceutical use thereof |
| abstract |
The present invention provides a binding molecule capable of binding to a human Nogo A polypeptide or human NiG or human NiG-D20 or human NogoA_342-357, having a dissociation constant of less than 1000 nM, a polynucleotide encoding the binding molecule; An expression vector comprising the polynucleotide; Expression systems comprising polynucleotides capable of producing binding molecules; Isolated host cell comprising an expression system as defined above; Use of said binding molecule as a pharmaceutical, in particular in the treatment of nerve repair; Pharmaceutical compositions comprising such binding molecules and methods of treating diseases associated with nerve repair. |
| priorityDate |
2003-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |